UCL School of Pharmacy represented at Royal Institution’s Future Pharma event
22 February 2018
On a bitterly cold Wednesday evening in January, 238 paying members of the public turned up to the Royal Institution’s Future Pharma event, filling the institution’s iconic lecture theatre.
In the same lecture theatre within which Michael Faraday announced his discoveries on electromagnetism and electrolysis, UCL School of Pharmacy Professors Ijeoma Uchegbu and Catherine Tuleu were honoured to describe their research on coating natural opioids with crab shell polymers and squirting them up the nose to treat severe pain and replacing alcohol in neonatal medicines to prevent adverse events in babies.
They were joined by UCL alumni Dr Sejal Ranmal of Intract Pharma and Dr Wafa Jamal of the University of Belfast as well as Stephen Hart of the UCL Institute for Child Health.
The talks ranged from the deadly serious subject of severe pain leading to suicide to the filling of “crapsules” with colon contents to treat serious debilitating conditions. A panel discussion followed the talks and the questions revealed the audience to be engaged and remarkably well informed.
The audience wanted to know when the discoveries would come to a clinic near them and what effect Brexit would have on pharmaceutical research and innovation. Uchegbu declared that Brexit would be “disastrous" for UK researchers as a hard Brexit would mean that they would lose the funding mechanism which currently allows them to collaborate with extraordinary researchers around Europe.
At the end of the one and a half hour event audience members queued up to ask the panellists yet more questions and the Royal Institution’s John Farrow described the evening as “brilliant”